大核心梗死取栓后不匹配特征对结局的时间依赖性影响
该研究为ANGEL-ASPECT试验的事后分析,评估大核心梗死患者中不匹配特征与发病至影像时间对血管内治疗(EVT)疗效的影响。结果显示,在早期时间窗(≤6小时)内,存在不匹配的患者接受EVT后90天改良Rankin量表(mRS)0-3分的比例更高,而无匹配者未见获益;晚期时间窗(>6小时)两组均无显著改善。所有交互检验均不显著,结果需前瞻性验证。
要点
- 大核心梗死患者中,早期时间窗内无匹配者接受EVT获益减弱。
- 早期时间窗内存在不匹配者,EVT与更高90天mRS 0-3分几率相关。
- 晚期时间窗(>6小时)无论有无匹配,EVT均未显著改善功能结局。
核心结论
- 在大核心梗死患者中,无匹配在早期时间窗更常见,且与EVT获益减少相关。
- 不匹配评估即使在早期就诊患者中也可能有助于治疗选择。
- 所有交互检验均不显著,结果仅为假设生成,需前瞻性预设确认。
研究设计与样本
- ANGEL-ASPECT试验的二次事后分析,纳入大核心梗死并随机接受EVT或内科治疗的患者。
- 按不匹配特征(不匹配比≥1.8且体积≥15 mL)和发病至影像时间(≤6小时 vs >6小时)分层分析。
主要发现
- 主要终点90天mRS 0-3分,治疗与时间交互P=0.412。
- ≤6小时层内,治疗与不匹配交互P=0.166;>6小时层内,交互P=0.301。
- 早期窗口(≤6小时)不匹配患者EVT组48.9% vs 28.4%达到mRS 0-3分,OR 2.41(95%CI 1.28-4.55),P=0.006。
- 早期窗口无匹配患者EVT组23.8% vs 27.3%,OR 0.83(95%CI 0.21-3.29),P=0.795。
- 晚期窗口(>6小时)两个亚组EVT均未与mRS 0-3分显著改善相关。
关键数值与推荐
- 不匹配定义为不匹配比≥1.8且体积≥15 mL。
- 早期时间窗定义为发病至影像时间≤6小时,晚期为>6小时。
- 主要终点为90天mRS 0-3分。
临床怎么用
- 对大核心梗死患者,尤其早期就诊者,可考虑评估不匹配特征以辅助EVT决策。
- 早期无匹配患者EVT获益可能有限,需个体化权衡。
- 晚期就诊患者无论有无匹配,EVT改善功能结局的证据不足。
局限性
- 为事后分析,所有交互检验不显著,结果仅为假设生成。
- 需前瞻性、预设的研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular therapy (EVT) has demonstrated efficacy in patients with large core infarctions, yet favorable outcomes remain limited. Although mismatch profiles have long informed EVT decision-making in small-core strokes, their prognostic significance in large-core infarcts remains uncertain and may be affected by time from symptom onset. This study aims to evaluate the relationship between mismatch profiles, time distribution, and EVT efficacy in patients with large ischemic cores. METHODS: This was a secondary posthoc analysis of the ANGEL-ASPECT trial (Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core) in patients with large ischemic cores randomized to EVT or medical management. The primary outcome was the modified Rankin Scale score of 0 to 3 at 90 days. Analyses were stratified by mismatch profile (mismatch ratio ≥1.8 and volume ≥15 mL) and onset-to-imaging time (≤6 hours versus >6 hours). RESULTS: For the primary end point (modified Rankin Scale score, 0-3 at 90 days), no significant treatment-by-time interaction was observed (P for interaction=0.412); within time strata, treatment-by-mismatch interaction tests were also nonsignificant (≤6 hours, P for interaction=0.166; >6 hours, P for interaction=0.301). In the early window (≤6 hours), EVT was associated with higher odds of favorable functional outcome (modified Rankin Scale score, 0-3 at 90 days) in patients with mismatch (48.9% versus 28.4%; odds ratio, 2.41 [95% CI, 1.28-4.55]; P=0.006), but not in those without mismatch (23.8% versus 27.3%; odds ratio, 0.83 [95% CI, 0.21-3.29]; P=0.795). In the late window (>6 hours), EVT was not associated with a significant improvement in modified Rankin Scale score 0 to 3 in either subgroup. CONCLUSIONS: Among patients with large infarct cores, the absence of mismatch was more common in the early time window and was associated with diminished benefit from EVT. These results suggest that mismatch evaluation-even in early presenting patients-may help inform treatment selection for patients with large ischemic cores. All interaction tests were nonsignificant; these findings are hypothesis‑generating and require prospective, prespecified confirmation. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04551664.
引用
- Chen J, Nie X, Wang M, et al. Time-Dependent Impact of Mismatch Profiles on Outcomes Following Endovascular Thrombectomy for Large Ischemic Stroke. Stroke. 2025. PMID: 41439308. doi:10.1161/STROKEAHA.125.052698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。